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Epstein–Barr virus (EBV) is a lymphotrophic herpesvirus infecting most of the world's population. It is associated with a number of human
lymphoid and epithelial tumors and lymphoproliferative diseases in immunocompromised patients. A subset of latent EBVantigens is required for
immortalization of primary B-lymphocytes. The metastatic suppressor Nm23-H1 which is downregulated in human invasive breast carcinoma
reduces the migration and metastatic activity of breast carcinoma cells when expressed from a heterologous promoter. Interestingly, the EBV
nuclear antigen 3C (EBNA3C) reverses these activities of Nm23-H1. The alpha V integrins recognize a variety of ligands for signaling and are
involved in cell migration and proliferation and also serve as major receptors for extracellular-matrix-mediated cell adhesion and migration. The
goal of this study was to determine if Nm23-H1 and EBNA3C can modulate alpha V integrin expression and downstream activities. The results of
our studies indicate that Nm23-H1 downregulates alpha V intregrin expression in a dose responsive manner. In contrast, EBNA3C can upregulate
alpha V integrin expression. Furthermore, the study showed that the association of the Sp1 and GATA transcription factors with Nm23-H1 is
required for modulation of the alpha V integrin activity. Thus, these results suggest a direct correlation between the alpha V integrin expression and
the interaction of Nm23-H1 with EBNA3C.
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Epstein–Barr virus (EBV) is a human gamma herpesvirus
which predominantly targets B cells and epithelial cells and is
associated with a number of human cancers including Burkitt's
lymphoma, Nasopharyngeal carcinoma, Hodgkin's disease,
AIDS-associated and transplant-associated immunoblastic lym-
phoma, and somewhat controversially invasive breast carcino-
ma (Brooks et al., 1997; Kieff, 1996; Rickinson and Kieff,
1996). EBV is also known to be the causative agent of infectious
mononucleosis (Brooks et al., 1997; Kieff, 1996; Rickinson and
Kieff, 1996). In vitro infection of B cells with EBV gives rise to
lymphoblastoid cell lines (LCLs) which express a subset of 12⁎ Corresponding author. Fax: +1 215 898 9557.
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doi:10.1016/j.virol.2006.03.031latent viral transcripts (Kieff, 1996; Rickinson and Kieff, 1996).
These 12 transcripts encode for six nuclear antigens (EBNAs),
three latent membrane proteins (LMPs), two early RNAs
(EBERs) and the BARF transcripts (Kieff, 1996; Rickinson and
Kieff, 1996). Of these six genes, EBNA1, LP, -2, -3A, -3C and
LMP1 have been shown to be important or critical for growth
transformation and immortalization of human primary B cells in
vitro (Kaye et al., 1993; Tomkinson et al., 1993; Cohen et al.,
1989).
The EBNA3 family contains a set of three genes tandemly
arranged on the EBV genome. The three proteins primarily
function as transcriptional regulators and contain similar
structural motifs as well as a region of limited homology in
the amino terminus (Kieff, 1996; Zhao et al., 1996). This
domain contains the binding site for the cellular repressor RBP-
Jκ also referred to as CSL (Robertson et al., 1996; Zhao et al.,
59T. Choudhuri et al. / Virology 351 (2006) 58–721996). EBNA3C can prevent binding of RBP-Jκ to EBNA2 and
can downregulate EBNA2-modified transactivation of the
LMP1 promoter through association of RBP-Jκ (Lin et al.,
2002; Marshall and Sample, 1995). Furthermore, EBNA3C can
regulate Cp, the major latent promoter controlling EBNA
expression, through RBP-Jκ and other co-repressors (Radkov et
al., 1997). EBNA3C has also been shown to play a role in
regulating the acetylation and co-activation activity of the p300/
ProTα complex (Subramanian et al., 2002a,b) and function as a
transcriptional repressor (Subramanian et al., 2002a,b; Zhao and
Sample, 2000).
Reverse genetic studies of EBV demonstrated that addition
of a stop codon after aa 365 in the EBNA3C open reading frame
nullified the ability of EBV to growth transform primary B
lymphocytes in vitro (Tomkinson et al., 1993). Cellular partners
previously identified include the metastasis suppressor Nm23-
H1 which bound to a short stretch of amino acids located
between the glutamine- and proline-rich domains of EBNA3C
(Subramanian and Robertson, 2002; Subramanian et al., 2001).
This interaction between Nm23-H1 and EBNA3C has been
shown to result in an increase in transcriptional activity when
tethered to a responsive promoter (Subramanian et al., 2001).
These results suggest that Nm23-H1 may possess transcrip-
tional regulatory activities independent of a possible role in
directly binding to DNA or through its interaction with
EBNA3C. Interestingly, the presence of EBNA3C mediates
the cellular translocalization of Nm23-H1 from a mostly
cytoplasmic to a predominantly nuclear signal (Subramanian
and Robertson, 2002) and reverses the antimigratory effects of
Nm23-H1 (Subramanian and Robertson, 2002).
The Nm23 gene family is a closely related group of
nucleoside dinucleotide phosphate kinases for which eight
distinct genes are known in humans (Nm23-H1 to -H8)
(Lacombe et al., 2000). The proteins are characterized by a
wide variety of functions including transcriptional regulation,
differentiation, proliferation and suppression of tumor metasta-
sis (Lacombe et al., 2000). Importantly, changes in cellular
levels of Nm23-H1 have been correlated with decreased
metastasis in a number of cancers including breast, gastric
and cervical cancers, and in vivo studies in nude mice have
demonstrated a role in suppressing metastasis (Miyazaki et al.,
1999; Tagashira et al., 1998; Leone et al., 1991, 1993). A
significant amount of data implicates Nm23-H1 in the
regulation of metastasis; however, the biochemical mechanism
for this activity is still poorly understood.
Integrins are heterodimeric molecules composed of a
noncovalently associated alpha and beta subunit exclusively
recognizing ligands via an RGD amino acid sequence (Hynes,
1992). The ligands for alpha V integrins include vitronectin,
bronectin, brinogen, von Willebrand factor and osteopontin
(Stamenkovic, 2000; Zhang et al., 1993; Denhardt and Guo,
1993; Busk et al., 1992; Charo et al., 1990; Smith et al., 1990;
Pytela et al., 1985). Interestingly, alpha V integrins are
expressed on migratory cells such as metastatic melanomas
and breast cancer cells and integrin expression correlates with
metastasis (Filardo et al., 1995; Nip et al., 1990; Albelda et al.,
1990). Additionally, αvβ3 is directly associated with matrixmetalloproteinase 2 (MMP2) on melanoma cells which is
thought to provide tumor cells with the coordinated matrix
degradation and cellular motility, thus facilitating cellular
invasion (Brooks et al., 1996).
The role of Nm23-H1 in regulating alpha V integrins has not
been previously investigated, and there are no direct report
indicating the relationship between Nm23-H1 and alpha V
integrin except in some clinical findings. Importantly, increased
expression of alpha V integrin correlates with EBV in infected B
cells (Huang et al., 2000). Moreover, LMP1, LMP2 and
EBNA2 expression has been shown to increase levels of alpha
V integrin in LCLs (Huang et al., 2000). In this report, we show
that the interaction of the essential EBV latent antigen EBNA3C
with Nm23-H1 also leads to increased expression of alpha V
integrin. Additionally, we show that Nm23-H1 in the absence of
EBNA3C decreased the expression of alpha V integrin. These
results provide in part an important clue towards understanding
the mechanism by which EBNA3C reverses the effects of
Nm23-H1 in regulating the proliferation and migration of
infected cells.
Results
Nm23-H1 and EBNA3C can modulate the transcription of
alpha V integrin promoter
Previous studies have shown that EBNA3C can reverse
Nm23-H1-mediated suppression of cell migration (Subrama-
nian et al., 2001). To further elucidate the mechanism by
which this occurs, we wanted to determine whether either or
both of these proteins could modulate the expression levels of
alpha V integrin, a protein found to play a key role in cell
migration and metastasis (Miyazaki et al., 1999; Tagashira et
al., 1998; Leone et al., 1991, 1993). The effect of these
proteins on the full-length alpha V integrin promoter inserted
into the pGL2 basic vector was assessed by luciferase reporter
assay. Expression vector pA3M-EBNA3C, pA3M-Nm23-H1
or both were transiently transfected into BJAB and DG-75
cells along with the pGL2, the reporter plasmid containing the
alpha V integrin promoter. Total transfected DNA was
balanced with empty vector, and transfection efficiency was
monitored by the use of pEGFP and counting of transfected
cells for GFP fluorescence. The results from this assay
demonstrated that the Nm23-H1 downregulated the alpha V
integrin promoter in a dose-dependent manner in both BJAB
and DG75 B-cell lines (Figs. 1A and D). Interestingly,
EBNA3C modestly activated the promoter in the context of
these two B-cell lines from a heterologous promoter (Figs. 1B
and E). However, when Nm23-H1 and EBNA3C were co-
expressed, there was an observed synergistic activation of the
promoter when compared to vector alone, thus nullifying the
repressive effects of Nm23-H1 (Figs. 1C and F). This result
indicates that EBNA3C and Nm23-H1 exhibit opposite effects
in terms of regulation of the alpha V integrin promoter in an
in vitro luciferase reporter assay but together they can
enhance the activation of the promoter as seen in BJAB and
DG75, respectively (Figs. 1C and F). To confirm the
Fig. 1. Modulation of alpha V integrin promoter by Nm23-H1 and EBNA3C in BJAB and DG75 cells. (A) pGL2-alpha V integrin promoter (2.5 μg) was co-transfected
with increasing amounts (2.5 μg, 5 μg, 7.5 μg) of pA3M-Nm23-H1, and 24 h post-transfected BJAB cells were harvested for luciferase assay. Increasing amounts of
Nm23-H1 showed a dose-dependent decrease of promoter activity. (B) pGL2-alpha V integrin promoter (2.5 μg) was co-transfected with increasing amounts (2.5 μg,
5 μg, 7.5 μg) of pA3M-EBNA3C, and 24 h post-transfected BJAB cells were harvested for luciferase assay. Increasing amounts of EBNA3C showed a dose-dependent
increase of promoter activity. (C) pGL2-alpha V integrin promoter (2.5 μg) was co-transfected with pA3M-Nm23-H1 (5 μg) and increasing amount (2.5 μg, 5 μg,
7.5 μg) of pA3M-EBNA3C. Twenty four hours post-transfected BJAB cells were harvested and lysed for luciferase assay. Increasing amount of EBNA3C showed an
increase of promoter activity in the presence of constant amount of Nm23-H1. (D) pGL2-alpha V integrin promoter (2.5 μg) was co-transfected with increasing
amounts (2.5 μg, 5 μg, 7.5 μg) of pA3M-Nm23-H1, and 24 h post-transfected DG75 cells were harvested for luciferase assay. Increasing amounts of Nm23-H1
showed a dose-dependent decrease of promoter activity. (E) pGL2-alpha V integrin promoter (2.5 μg) was co-transfected with increasing amounts (2.5 μg, 5 μg,
7.5 μg) of pA3M-EBNA3C, and 24 h post-transfected DG75 cells were harvested for luciferase assay. (G) pGL2-alpha V integrin promoter (2.5 μg) was co-transfected
with pA3M-Nm23-H1 (5 μg) and increasing amount (2.5 μg, 5 μg, 7.5 μg) of pA3M-EBNA3C. 24 h post-transfected DG75 cells were harvested and lysed for
luciferase assay. Fractions of lysates were used for Western blot with anti-EBNA3C to detect the EBNA3C and anti-myc for Nm23-H1 in all the data presented above.
(G) Total RNA from 24 h post-transfected cells (vector only, Nm23-H1, EBNA3C and both Nm23-H1 and EBNA3C) DG75 and BJAB was used to make cDNA. The
specific primers for alpha V. The cDNAwas amplified using SYBR green real-time master mix. Data show that in Nm23-H1 overexpressing cells the level of alpha V
integrin reduced to greater than 50-fold over vector alone and in EBNA3C overexpressed cells, there were a small increase in activity. In EBNA3C and Nm23-H1 co-
expressing cells, transcript level was close to the vector alone. Means and standard deviations were derived from three independent experiments in all the above
presented data.
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Fig. 2. Alpha V integrin expression level was decreased in Nm23-H1 overexpressed MDA-MB-435 cells. (A) MDA-MB-435 cells stably overexpressing Nm23-H1 as
well as expressing EBNA3C or both proteins together were harvested, fixed and stained with alpha-V-integrin-specific mouse monoclonal antibody and further
detected by goat anti-mouse secondary antibody conjugated with FITC. Cells were analyzed in FACS Caliber. Data presented in histogram as FL1 in x axis. In the right
panel, the change of alpha V integrin expression from the FACS data showed in bar diagram. In Nm23-H1 overexpressing cells, the level of alpha V integrin reduced to
greater than 40-fold over vector alone control in this assay. (B) MDA-MB-435 cells stably overexpressing Nm23-H1 as well as expressing EBNA3C or both proteins
together were grown overnight on cover slip, fixed and stained with alpha-V-integrin-specific mouse monoclonal antibody and further detected by goat anti-mouse
conjugate with FITC. Nuclei were stained with DAPI. Immunofluorescence showed reduced cytoplasmic expression of alpha V integrin in Nm23-H1 overexpressing
cells.
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was performed, and specific signals were detected using
specific antibodies for myc (Nm23-H1 was originally cloned
upstream of a myc tag in the pA3M vector) and EBNA3C
respectively while the protein levels were determined by β-
actin Western blot.
To corroborate the above results, we performed a semi-
quantitative real-time PCR analysis. Expression vector pA3M-
EBNA3C, pA3M-Nm23-H1 or both were transiently trans-
fected into BJAB and DG-75 cells along with the pA3M vector
alone. Real-time PCR for alpha V integrin expression performed
as described in Materials and methods. The results show that in
Nm23-H1 overexpressing cells the level of endogenous alpha V
integrin was reduced to greater than 50-fold over vector alone
control in this assay in both cell lines (Fig. 1G). As expected,
when EBNA3C was expressed, there was a modest increase inFig. 3. Modulation of alpha V integrin promoter by Nm23-H1 and EBNA3C is ind
integrin promoter (2.5 μg) was co-transfected with increasing amounts (1 μg, 2 μg, 5
cells were harvested for luciferase assay. Increasing amounts of EBNA3C showed
promoter (2.5 μg) was co-transfected with pA3M-Nm23-H1 (1 μg) and increasing a
post-transfection, BJAB cells were harvested and lysed for luciferase assay. Increasing
promoter activity in the presence of constant amount of Nm23-H1. (C) pGL2-alpha
2 μg, 5 μg) of mutant pA3M-EBNA3C (Δ561–675), and 24 h post-transfection, D
showed a dose-dependent increase in the promoter activity. (D) pGL2-alpha V int
increasing amounts (1 μg, 2 μg, 5 μg) of pA3M-EBNA3C (Δ561–675). Twenty four h
Increasing amounts of pA3M-EBNA3C (Δ561–675) showed a dose-dependent in
Fractions of lysates were used for Western blot with anti-myc to detect pA3M-EBN
derived from three independent experiments in all the above presented data.activity (Fig. 1G). Importantly, when EBNA3C and Nm23-H1
were co-expressed, the alpha V integrin transcript levels were at
least 2 logs above that seen for Nm23-H1 alone (Fig. 1G,
compare lane 2 and 4).
To further support the results of the luciferase reporter assay,
FACS and IF analysis were performed. MDA-MB-435 cells
stably expressing Nm23-H1 as well as expressing EBNA3C or
both proteins together were harvested, fixed and stained with
alpha-V-integrin-specific antibody. The flow cytometry data
show that in Nm23-H1 overexpressing cells the level of alpha V
integrin reduced to greater than 40-fold over vector alone
control in this assay (Fig. 2A). In comparison, when EBNA3C
was expressed or co-expressed with Nm23-H1, a clear increase
in signals above that of Nm23-H1 alone was observed (Fig.
2A). Similarly, experiment done in transiently transfected BJAB
cells (Nm23-H1, EBNA3C alone and both protein co-ependent to their interaction with each other in BJAB cells. (A) pGL2-alpha V
μg) of mutant pA3M-EBNA3C (Δ561–675), and 24 h post-transfection, BJAB
a dose-dependent increase in the promoter activity. (B) pGL2-alpha V integrin
mounts (1 μg, 2 μg, 5 μg) of pA3M-EBNA3C (Δ561–675). Twenty four hours
amounts of pA3M-EBNA3C (Δ561–675) showed a dose-dependent increase of
V integrin promoter (2.5 μg) was co-transfected with increasing amounts (1 μg,
G75 cells were harvested for luciferase assay. Increasing amounts of EBNA3C
egrin promoter (2.5 μg) was co-transfected with pA3M-Nm23-H1 (1 μg) and
ours post-transfection, DG75 cells were harvested and lysed for luciferase assay.
crease of promoter activity in the presence of constant amount of Nm23-H1.
A3C (Δ561–675) and pA3M-Nm23-H1. Means and standard deviations were
63T. Choudhuri et al. / Virology 351 (2006) 58–72expressed) showed a similar pattern of results as compared to
the MDA-MB-435 cell lines (data not shown). In addition,
immunofluorescence analysis of the stable cell lines for alpha V
integrin suggests a similar pattern based on fluorescent intensity
using confocal microscopy (Fig. 2B) corroborating the above
FACS data.
Regulation of the of alpha V integrin promoter by Nm23-H1
and EBNA3C is independent of their interaction with each
other
Previous studies have shown that the region downstream of
aa 365 to 992 of EBNA3C was important in mediating B-cell
immortalization (Tomkinson et al., 1993). The metastasis
suppressor Nm23-H1 was found to bind to a short stretch of
amino acids located between the glutamine- and proline-rich
domains of EBNA3C, suggesting an important role for the
interaction of Nm23-H1 and EBNA3C (Subramanian et al.,
2001, 2002a,b).To determine if EBNA3C and Nm23-H1 can
cooperate in regulating the alpha V integrin expression, we used
an EBNA3C expression vector deleted for the Nm23-H1
interacting domain (Δ561–675) and a Nm23-H1 expression
plasmid that was shown in previous assays to suppress alpha V
integrin transcription. The pA3M-EBNA3C (Δ561–675) and
pA3M-Nm23-H1 expression plasmids were transiently trans-
fected into BJAB cells along with the luciferase reporter
plasmid containing the alpha V integrin promoter. Total
transfected DNA was balanced with empty vector, and
transfection efficiency was monitored by the use of pGFP and
counting of transfected cells for GFP fluorescence. The results
showed that the mutant EBNA3C (Δ561–675) moderately
activated the alpha V promoter in a dose-dependent manner up
to 2.5-fold over vector alone in BJAB cells (Fig. 3A) and 6-fold
in DG-75 cells (Fig. 3C). However, the Nm23-H1 induced
reduction was reversed to 20- and 40-fold in BJAB and DG75
respectively (Figs. 3B and D). Therefore, the suppression of the
alpha V integrin expression by Nm23-H1 can be at least in part
reversed by the expression of EBNA3C in this system.
However, the revelation of this effect with an EBNA3C
molecule which lacks the domain sufficient for binding to
Nm23-H1 suggests that this effect is likely to be independent of
a direct interaction.
The cellular transcription factor GATA-1 and Sp1 are
important for modulation of alpha V integrin promoter
Since neither EBNA3C nor Nm23-H1 has been shown to
regulate transcription by directly binding DNA, we looked
for possible transcription factors that might be targeted
resulting in functional regulation of the alpha V integrin
promoter. Sp1 have been previously shown to be transacti-
vator of alpha V integrin expression (Czyz and Cierniewski,
1999). EBNA3C has also been shown to contain a region
with homology to the glutamine-rich activation domain of
Sp1 which can function as a transcriptional activator when
fused to the Gal4 DNA binding domain (Bain et al., 1996).
On the other hand, GATA-1 binding to the alpha V promoternegatively regulates expression of the alpha V integrin
subunit in human leukemic K562 cells (Czyz et al., 2002).
Reporter luciferase plasmids with targeted truncations which
remove the Sp1 and GATA-1 binding sites of the alpha V
integrin promoter were used in luciferase assays as described
above. The results of these assays showed that the reporter
constructs deleted for the GATA-1 or Sp1 had little or no
apparent change in activity when compared with vector alone
control (data not shown). However, when assayed in the
context of Nm23-H1 expression, again, a reduction in
activity levels was seen (Fig. 4A). Most interestingly,
introduction of EBNA3C did not reverse the level of
suppression seen by Nm23-H1, suggesting that EBNA3C
effect is outside of the region containing the cis-acting
elements for NF-κb and GATA-1 binding (Fig. 4A).
Furthermore, a reporter plasmid deleted for the NF-κb site
from −481 to −522 but retaining the element from +169 to
−482 was able to reverse the repression by Nm23-H1, when
EBNA3C was added to about 75% of the vector alone
control and 3-fold over Nm23-H1 (Fig. 4B). Together, these
results suggest that NF-κb may not play a role in regulating
the level of repression of Nm23-H1 as the levels of
repression were more substantial when the NF-κb site was
deleted (Fig. 4, compare A and B). To further explore the
role of NF-κb, GATA-1 and Sp1 and their binding sites in
regulation of alpha V integrin expression in the presence of
Nm23-H1 and EBNA3C, we used a construct containing the
AP1 and CTC binding site but deleted for other additional
sites above (Fig. 4D). The results of the reporter luciferase
assay suggest that the majority of the activity in the context
of Nm23-H1 and EBNA3C lies with Sp1, NF-κb and
GATA-1 as there was minimal changes in the levels seen in
the construct with AP1 and CTC site (Fig. 4C). The fact that
the changes seen when the NF-κb site was deleted with
EBNA3C was almost identical with about 50% of the vector
alone indicates that, although NF-κb may be important for
the Nm23-H1 effect, it does not play a major role in the
ability of EBNA3C to rescue the repression by Nm23-H1.
To more specifically address the role of GATA-1 and Sp1, we
generate reporter mutants having the two GATA-1 transcription
binding site mutated and all the three Sp1 transcription binding
site mutated. Studies using the GATA-1 mutant reporter plasmid
showed that there was a negligible change in activity in the
presence of Nm23-H1 (Fig. 4E). In contrast, the Sp1 mutated
reporter plasmid showed about a 50% reduction of activity in
the presence of Nm23-H1 (Fig. 4F). Furthermore, we noticed
that in Sp1 mutated reporter plasmids there was little or no
effect of EBNA3C on the promoter activity (Fig. 4F). These
results indicate that the effects of Nm23-H1 and EBNA3C are
predominantly through the GATA-1 and Sp1 transcription
factors, respectively.
Nm23-H1 forms a complex with the cellular transcription
factor GATA-1 in B cells
Data above strongly suggest that Nm23-H1 can down-
regulate the expression of alpha V integrin through interactions
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demonstrate whether this is through a direct association,
EMSA and GST binding experiments were performed using
specific antibodies against GATA-1. The results of the
luciferase reporter promoter assays indicated that the GATA
binding sites within the alpha V integrin promoter are critical
for Nm23-H1-mediated downregulation. Therefore, we
wanted to determine whether these proteins were regulatingalpha V integrins through transcription-factor-mediated DNA
binding.
EMSA showed a specific GATA shift observed in BJAB
nuclear extract (NE) (Fig. 5). The specificity of this shift was
verified through the disappearance of the shift in the presence of
specific competitor (Fig. 5, compare lanes 1, 2 and 5). The shift
was not disrupted when we used a non-specific cold competitor
(Fig. 5, lane 7). The mobility of the GATA-1 probe was reduced
Fig. 5. Nm23-H1 form complexes with GATA-1 transcription factor when it was
bound to the cognate sequences demonstrated in EMSA. Probe containing
GATA-1 binding site of alpha V integrin promoter along with the flanking bases
was labeled with (32P-αdCTP) and used for binding in the presence of in vitro
translated Nm23-H1 and EBNA3C. Lanes 1 and 2, probe with and without
BJAB nuclear extract (NE). Lane 3 is probe with NE and IVT Nm23-H1
showing shift due to binding of GATA-1 in NE to probe (*). Lanes 5 and 7 are in
the presence of specific and non-specific cold competitors, respectively. Lane 4
is showing supershift of the Nm23-H1 and GATA-1 complex in the presence of
Nm23-H1-specific antibody (**). Lanes 6, 8 and 9 showing that there were no
shifts in the presence of rabbit reticulocytes, IVT EBNA3C and c-myc antibody
alone, but we observe a shift in the presence of both IVT Nm23-H1 and IVT
EBNA3C in lane 10 (*). Lane 11 shows the specific supershift due to GATA-1
specific antibody (**).
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Nm23-H1 (Fig. 5, lane 3). The presence of Nm23-H1 in the
complex was verified by additional supershifting in the
presence of anti-myc antibody (1 μg) used to detect Nm23-
H1 (Fig. 5, lane 4). BJAB NE where EBNA3C was in vitro
translated had no obvious effect on the mobility of the GATA
probe at this level of detection (Fig. 5, lane 8). The BJAB NE
with mixture of both in vitro translated EBNA3C and Nm23-H1
reduced the mobility of the probe to the same extent as that seen
with the Nm23-H1 and BJAB NE alone (Fig. 5, lane 10). There
was no apparent change on effect when we used unprogrammed
the rabbit reticulocytes (Fig. 5, lane 6). GATA-1-specific
antibody (1 μg) showed a specific supershift (Fig. 5, lane 11).
Additionally, no specific shift was observed with myc antibody
alone (Fig. 5, lane 9). These results suggest that EBNA3C and
Nm23-H1 are targeting distinct element within the alpha V
integrin promoter and therefore may regulate expression
through interaction with different factors bound to the promoter.
A GST-Nm23-H1 pull-down assay was also performed from
an NIH3T3 Nuclear extract previously shown to have detectable
levels of GATA-1 (Aumont et al., 1993). The results of these
binding experiments suggest that Nm23-H1 can associate with
GATA-1 in human cell line but not EBNA3C (Fig. 6). The
control GST fusion protein alone did not show any specific
association with GATA-1 (Fig. 6). Truncated mutants of
EBNA3C were used to determine if specific domains of
EBNA3C may bind to GATA-1. These mutants were selected
from the regions of EBNA3C which include the N-terminal, C-
terminal and the region of EBNA3C previously shown to bind
to Nm23-H1 (Subramanian and Robertson, 2002). However,
the results indicated little or no interaction with GATA-1 (Fig.
6). Therefore, these studies suggest that Nm23-H1 may form a
complex with GATA-1 bound to its cognate sequence, down-
regulating transcription of the alpha V integrin promoter.
EBNA3C associates with the cellular transcription factor Sp1
bound to DNA
The above data strongly suggest that EBNA3C can
upregulate the expression of alpha V integrin through interac-
tions with the cellular transcription factor Sp1. To show thatFig. 4. Transcription factors GATA and Sp1 are important for alpha V integrin promo
κB and GATA transcription factor binding sites was modulated by Nm23-H1. 2.5 μg o
pA3M-Nm23-H1 or 2.5 μg EBNA3C or both protein together. Luciferase assay do
presence of Nm23-H1. (B) Alpha V integrin promoter region having GATA, Sp1 and
Nm23-H1. 2.5 μg of pGL2-alpha V integrin promoter (−482 + 169) was co-transfe
Twenty four hours post-transfection, the harvested cells showed an increase in the pro
presence of Nm23-H1. Decrease of expression was also observed in the presence of b
not modulate by either EBNA3C or Nm23-H1. 2.5 μg of pGL2-alpha V integrin prom
EBNA3C and both protein. Twenty four hours post-transfection, cells were harves
presence of either of the proteins. (D) Schematic of alpha V integrin promoter indicati
used in the above assay. (E) Alpha V integrin promoter not having GATA-1 binding
(GATA-1 mutant) was co-transfected either with 2.5 μg pA3M-Nm23-H1 or 2.5 μ
harvested and lysed for luciferase assay. No significant change was observed in the p
Alpha V integrin promoter not having Sp1 binding site did not modulate by EBNA3
either with 2.5 μg pA3M-Nm23-H1 or 2.5 μg EBNA3C and both protein. Twenty fou
significant change was observed in the presence of EBNA3C but a significant change
by Western blot. Means and standard deviations were derived from three independethis occurs through a direct association with the Sp1 cellular
factor, an EMSA experiment was performed using antibodies
specific for the Sp1 transcription activators. The results of
the luciferase reporter promoter mutants indicated that Sp1
binding sites within the alpha V integrin promoter are critical for
EBNA3C-mediated upregulation of alpha V integrin. Therefore,
we wanted to test whether these proteins were regulating alpha
V integrins through transcription-factor-mediated DNA
binding.ter modulation in BJAB cells. (A) Alpha V integrin promoter region having NF-
f pGL2-alpha V integrin promoter (−552–410) co-transfected with either 2.5 μg
ne at 24 h post-transfection showed decreased alpha V promoter activity in the
AP1 transcription factor binding sites was modulated by EBNA3C and also by
cted either with 2.5 μg pA3M-Nm23-H1 or 2.5 μg EBNA3C or both proteins.
moter activity. In contrast to that, promoter activity was sharply decreased in the
oth proteins. (C) Alpha V integrin promoter containing only AP1 binding site did
oter (−391–44) was co-transfected either with 2.5 μg pA3M-Nm23-H1 or 2.5 μg
ted and lysed for luciferase assay. No significant change was observed in the
ng the transcription factor binding sites along with the truncated/deletion mutant
site did not modulate by Nm23-H1. 2.5 μg of pGL2-alpha V integrin promoter
g EBNA3C and both protein. Twenty four hours post-transfection, cells were
resence of Nm23-H1 but a significant change in the presence of EBNA3C. (F)
C. 2.5 μg of pGL2-alpha V integrin promoter (Sp1 mutant) was co-transfected
r hours post-transfection, cells were harvested and lysed for luciferase assay. No
in the presence of Nm23-H1. Fractions of lysates were used to detected proteins
nt experiments in all the above presented data.
Fig. 6. Nm23-H1 but not EBNA3C truncated mutants bind with GATA-1 in NIH3T3 nuclear extract (NE). NIH3T3 nuclear extract incubated with GST and Nm23-H1
GST along with the mutants E3C-GST (1–365, 366–581, 582–792, 629–910, 900–992) protein for 3 h. Bound protein was resolved on 12% SDS-PAGE, transferred
and detected using anti-GATA (rat monoclonal) antibody. Relative bindings are shown in bar diagram.
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nuclear extract (Fig. 7). The specificity of the shift was verified
by its disappearance in the presence of cold specific competitor
(Fig. 7, compare lanes 1, 2 and 5). The shift was not lost when a
non-specific cold competitor was used (Fig. 5, lane 6). The
mobility of the Sp1 probe was reduced by the NE from BJAB
cells and further in the presence of in vitro translated EBNA3C
(Fig. 7, lane 3). The presence of EBNA3C in the complex was
further verified by additional supershifting in the presence of a
specific anti-EBNA3C (myc ascites, 1 μg) antibody (Fig. 7, lane
4). BJAB NE where Nm23-H1 was in vitro translated had no
obvious effect on the mobility of the Sp1 probe at this level of
detection (Fig. 7, lane 8). The BJAB NE and mixture both in
vitro translated EBNA3C and Nm23-H1 reduced the mobility
of the probe to the same extent as that seen with the EBNA3C
and BJAB NE alone (Fig. 7, lane 10). These results suggest thatEBNA3C and Nm23-H1 are binding to factors at different
positions of the alpha V integrin promoter to regulate
expression. The unprogrammed rabbit reticulocyte had no
effect (Fig. 7, lane 11). However, the Sp1-specific antibody
(1 μg) supershifted the complex (Fig. 7, lane 9). Additionally,
no specific shifts were observed with antibody alone (Fig. 7,
lane 7). These results strongly suggest that EBNA3C can
associate with the transcription activators Sp1 mediating
upregulation of alpha V integrin transcription.
Nm23-H1 downregulates the autophosphorylation of FAK at
Tyr397
Focal adhesion kinase (FAK) is a central player in the control
of the cell migration by activating autophosphorylation at Tyr397
(Cooper et al., 2002; Hynes, 1992). Additionally, αVβ3 ligation
Fig. 7. EBNA3C form complexes with Sp1 transcription factor to its cognate
sequences. A probe for Sp1 (GC Box) binding site of alpha V integrin promoter
along with the flanking bases was labeled with (32P-αdCTP) and used for
binding in the presence of in vitro translated Nm23-H1 and EBNA3C. Lanes 1
and 2, probe with and without BJAB nuclear extract (NE). Lane 3 is probe with
NE and IVT EBNA3C showing shift due to binding to Sp1 (*). Lanes 5 and 6 are
with specific and non-specific cold competitors along with probe, NE and IVT
EBNA3C myc tagged. Lane 4 shows the supershift of EBNA3C and Sp1
complex in the presence of anti-myc (**) antibody. Lanes 11, 8 and 7 containing
rabbit reticulocytes, IVT Nm23-H1 and anti-myc alone, respectively, had no
affect on probe mobility, whereas the presence of both IVT Nm23-H1 and IVT
EBNA3C in lane 10 showed shift in the mobility (*). Lane 9 shows supershift in
the presence of Sp1-specific antibody (**).
Fig. 8. Autophosphorylation of FAK in the presence of Nm23-H1 and EBNA3C.
(A) Lysates of MDA-MB-435 cells grown in the presence of vitronectin vector
control (1), stably transfected with Nm23-H1 (2), stably transfected with E3C
(3), stably co-transfected with Nm23-H1 and E3C (4) and vector control in the
presence of LM609 (5) were immunoblotted with rabbit polyclonal anti-FAK
and mouse monoclonal anti-Phospho-FAK (Y397) and then normalized with β-
actin. (B) In cell Western, MDA-MB-435 cells grown in the presence of
vitronectin vector control (1), stably transfected with Nm23-H1 (2), stably
transfected with E3C (3), stably co-transfected with Nm23-H1 and E3C (4) and
vector control in the presence of LM609 (5) and presented autophosphorylation
with respect to the basal level of FAK. Means and standard deviations were
derived from three independent experiments.
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nent) activates FAK. We used the breast cancer cell line MDA-
MB-435 stably transfected with EBNA3C, Nm23-H1 and both
constructs along with the empty vector control so as to have
consistent expression with majority of cells compared to
transient expression. Upon inducing αVβ3 with vitronectin for
24 h, we analyzed the level of autophosphorylation along with
the basal level of FAK by Western blot and in cell Western
analysis.
Our Western blot results showed that there was no change in
expression of basal level of FAK in the stable cell lines
including the control MDA-MB-435 cells treated with the
specific inhibitor of αVβ3 receptor (Tucker, 2003). Interest-
ingly, we observed a 3-fold reduction of autophosphorylation
at FAK-Tyr397 in the cell expressing Nm23-H1 (Fig. 8A). A
similar trend in activity is seen as observed by the in cell
Western study (Fig. 8B) when comparing the results in the
presence of the specific inhibitor LM609 (Fig. 8B, compare
lane 2 and 5).
Discussion
EBV transformation of B-lymphocytes requires a subset of
six latent proteins including EBNA3C (Subramanian et al.,
2002a,b). EBNA3C has been shown to function as a
transcriptional activator or repressor depending on its interac-
tion with specific cellular factors (Subramanian et al., 2002a,b).
Previous studies have shown that EBNA3C can also repress the
major LMP1 latent promoter in large part through its interaction
with the RBP-Jκ transcription repressor, through disruption of
the EBNA2/RBP-Jκ interaction as well as the interaction ofRBP-Jκ with its cognate sequence within the LMP1 promoter
(Robertson et al., 1995, 1996; Marshall and Sample, 1995). In
this report, we show interactions between EBNA3C and the
cellular transcription factor Sp1.
The interaction between EBNA3C and Nm23-H1 and
resulting downstream effects is important to understand the
mechanism by which this essential viral oncoprotein and the
known cellular metastasis suppressor can regulate cell prolif-
eration and cell migration in vitro in EBV-positive tumors
(Subramanian et al., 2001). The region of EBNA3C which
binds Nm23-H1 has been mapped to a 39-aa carboxy-terminal
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domains of the protein (Subramanian and Robertson, 2002).
The location of this binding site is interesting because the
glutamine-rich region is known to function as a transactivation
domain, suggesting that its interaction with Nm23-H1 may
affect the ability of EBNA3C to regulate transcription.
Moreover, it has previously been shown that EBNA3C can
increase Nm23-H1-mediated activation of a basal promoter, and
this effect is dependent on the glutamine-rich region since the
Nm23-H1 binding domain alone had little effect on activation
(Subramanian and Robertson, 2002). Thus, the interaction
domain may serve as a recruitment domain for the glutamine-
rich functional activator of EBNA3C.
The mechanism by which EBNA3C is able to reverse the cell
migratory effects of Nm23-H1 is not known, though it has been
suggested that it may in part be due to upregulation of adhesion
molecules E-cadherin and α-integrins (Subramanian et al.,
2001). There are also reports indicating the possible role of
MMP-9 (Kuppers et al., 2005). Additionally, it is also possible
that other functional effects of Nm23-H1 may be affected by
EBNA3C. Here, in this report, we specifically focused on alpha
V integrin. Alpha V integrin is one of the major proteins
reported to be a key player in cancer development and
progression (Cooper et al., 2002; McGary et al., 2002; Weber,
2001; Ruoslahti, 1996; Cheresh, 1991). Here, we report an
observed increase in alpha V integrin expression in the presence
of EBNA3C. In contrast, we observed a decrease in expression
in the presence of Nm23-H1. Thus, these two proteins can
counteract the effect of each other at least in terms of alpha V
integrin expression. In the line of counteractive theory, these
proteins may also antagonize each other either by direct
interaction through a large complex or through the effects of
independent complex. Thus, a possible mechanism of by which
EBNA3C can induce cell migration and possibly metastasis is
by regulating the alpha V integrin signaling pathway.
Promoter studies of alpha V integrins give us an indication
that Nm23-H1 clearly downregulated the promoter in two
different B-cell lines. The semi-quantitative real-time PCR
analysis also supported these conclusions. These data were
further supported by the FACS and IF findings which show that
there was a definite decrease of expression of alpha V integrin in
MDA-MB-435 cells with stably expressing Nm23-H1. Dele-
tion- and site-specific mutational analysis of the alpha V integrin
promoter revealed that GATA-1 is a critical component for
Nm23-H1-mediated downregulation while Sp1 has a more
pronounced role in EBNA3C-mediated upregulation. Analysis
of the specific GATA-1 and Sp1 mutants of alpha V integrin
promoter confirmed our hypothesis. The results of this transient
reporter studies were further supported by EMSA and GST
binding results, from BJAB and NIH3T3 cells which demon-
strated the same general trend as the reporter assay. These studies
corroborated the finding that both Nm23-H1 and EBNA3C can
counter the effect of each other by direct association or indirectly
through association with other known transcription activators to
regulate the alpha V integrin promoter.
Nm23-H1 has been shown to localize to the cytoplasm;
however, in the presence of EBNA3C, its localization wasshown to shift to an almost exclusively nuclear signal
(Subramanian et al., 2001). This change in localization
strengthens the possibility that Nm23-H1 may function as a
transcriptional regulator. However, in uninfected cells, low
levels have been detected in the nucleus, suggesting that a
cellular partner may play a role in this translocation or that
Nm23-H1 itself maybe post-translationally modified to mediate
this event. Unpublished data in our laboratory have shown that
Nm23-H1 can bind to Nm23-H2 (Choudhuri and Robertson,
unpublished data), the predominantly nuclear family member
supporting a potential role for Nm23-H1 in the nucleus
independently or in association with Nm23-H2.
Based on our promoter analyses data and GST results, we
have determined that Nm23-H1 and EBNA3C bind to the cellu-
lar transcription activators GATA-1 and Sp1, respectively. Addi-
tionally, gel shift study suggests that these associations are
important for the regulation of the alpha V integrin promoter.
This finding is the first report of the association of Nm23-H1
with cellular transcription factor GATA-1. The reporter analyses
provide strong evidence that Nm23-H1 is capable of regulating
cellular proteins through its interaction with transcription acti-
vators bound to their responsive elements within the promoter of
the target molecules. It has also been suggested that Nm23-H1
may directly bind DNA as reported, showing repression of
transcriptional activity of the platelet-derived growth factor-A
(Ma et al., 2002). Additionally, another report showed that alpha
V integrin is negatively regulated by the GATA-1 (Czyz and
Cierniewski, 1999). This study has been further confirmed by
data from EMSA and also by the in vivo GST binding. However,
we have not been able to show that Nm23-H1 directly bound to
DNA in our studies after multiple attempts. Additional studies
are required to elucidate this potential dual effect on transcrip-
tional regulation mediated by Nm23-H1.
The EMSA data provide convincing evidence that EBNA3C
and Nm23-H1 can act independently to regulate alpha V
integrin primarily through the GATA-1 and Sp1 transcription
factors respectively bound to the alpha V integrin promoter.
Translocation of Nm23-H1 to the nucleus followed by binding
to GATA-1 bound to its cognate sequence can negatively
regulate the promoter activity. However, it should be noted that
GATA-1 was previously shown to negatively control the alpha
V integrin promoter (Czyz et al., 2002). Moreover, the same
study showed that the Sp1 binding site located within the alpha
V integrin promoter can influence upregulation of the
expression (Czyz and Cierniewski, 1999). Our EMSA data
show that both Nm23-H1 and EBNA3C can bind to GATA-1
and Sp1, respectively, complexed to their cognate sequences
thus regulating expression. In addition, EBNA3C and Nm23-
H1 may interact with each other in omplex with GATA-1 and
Sp1 at the promoter, thus leading to activation of transcription.
Furthermore, we also showed that Nm23-H1 was able to
downregulate one of the downstream factors of the αVβ3
signaling pathways (Parsons, 2003). The downregulation of
autophosphorylation in FAK at Y397 by Nm23-H1 was
dramatically reversed in the presence of EBNA3C possibly
through translocation of Nm23-H1 to the nucleus (see model in
Fig. 9).
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the difference in viral protein expression across the latency
programs established by EBV. However, the potential for
regulation of metastasis does exist with the viral-associated
cancers (Rickinson and Kieff, 1996). The overall role of
EBNA3C in this process may only be one aspect of this
complicated regulatory pathway in that its expression so far has
been detected mostly in type III latency (Young and Murray,
2003; Rickinson and Kieff, 1996). Only a few known EBV-
associated cancers are associated with the latency III program,
and they are predominantly seen in immunocompromised
patients (Rickinson and Kieff, 1996). However, the expression
of EBNA3C during the initial or early stages of infection in
other positive cancers is possible and may shed light on its
potential role in regulating genes involved in cell migration
(Subramanian et al., 2001). In addition, the prevalence of HIV
and transplants-associated lymphomas continues to rise;
therefore, the importance of EBNA3C in EBV-associated
malignancies is also expected to increase as the incidence of
these cancers increases (Fig. 9).
Materials and methods
Cell lines and antibodies and constructs
BJAB and DG75 cells are EBV-negative B cells isolated
from Burkitt's lymphoma patients and were provided by Elliott
Kieff (Brigham and Womens Hospital, Boston, MA). B-cell
lines were grown in RPMI 1640 medium (Hyclone, Logan, UT)
supplemented with 10% bovine growth serum, 2 mM glutamine
and 25 U/ml penicillin/streptomycin. Human breast cancer cells
MDA-MB-435 were maintained in DMEM (Hyclone, Logan,Fig. 9. Hypothetical model for the regulation of alpha V integrin promoter by EBNA
possibly independent to their interaction with each other. Downregulation of the alp
contrast, EBNA3C upregulates alpha V integrin expression through binding to Sp1
adhesion kinase (FAK) at Tyr397 and thus blocks the αvβ3 pathway.UT) supplemented with 10% bovine growth serum, 2 mM
glutamine and 25 U/ml penicillin/streptomycin.
A rat monoclonal antibody against GATA-1 (E-3) and a
rabbit polyclonal antibody against alpha V integrin (sc-52) were
obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA). Polyclonal rabbit anti-FAK (556368) and mouse mono-
clonal FAK-pY397 (611806) were purchased from BD
Biosciences (Beverly, MA). The specific inhibitor of αVβ3
mouse monoclonal antibody was obtained from Chemicon
(Temecula, CA). A10 monoclonal reactive to EBNA3C and
anti-myc ascites reactive to myc has been previously described
Knight et al. (2001).
The alpha V integrin reporter plasmid was provided by Glen
Nemerow (Scripps Research Institute, La Jolla, CA), and the
specific truncations were sub-cloned in the lab in pGL2 basic
plasmid. The alpha V integrin promoter with deleted GATA-1
and deleted Sp1 transcription sites was generated by PCR-based
site mutagenesis.
Transfection
BJAB, DG-75 and MDA-MB-435 cells were transfected
by electroporation using a BioRad Gene Pulser II electro-
porator. Ten million cells were collected and washed once in
phosphate-buffered saline. The cells were then resuspended in
400 μl of either DMEM or RPMI 1640 containing DNA
normalized to balance total DNA, and transfection efficiency
was determined by GFP expression as an internal control.
Once resuspended, the cells were transferred to 0.4 cm elec-
troporation cuvettes and electroporated at 975 μF and 220 V
for BJAB, DG-75 and MDA-MB-435 cells. Following elec-
troporation, the cells were plated in 10 ml of supplemented3C and Nm23-H1. Regulation of alpha V integrin by Nm23-H1 and EBNA3C is
ha V integrin activity by Nm23-H1 is mediated through binding to GATA-1. In
transcription factor. Nm23-H1 also inhibits the autophosphorylation of focal
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being harvested.
Luciferase assay
Ten million BJAB, DG-75 and MDA-MB-435 cells were
collected at a concentration of 5 × 105/ml and transfected as
described above. Twenty hours post-transfection, the cells were
harvested, washed in PBS and lysed in 400 μl of Reporter Lysis
Buffer (Promega, Inc., Madison, WI). A 40-μl aliquot of the
lysate was then mixed with 100 μl of luciferase assay reagent in
an Opticomp Luminometer (MGM Instruments, Inc., Hamden,
CT), and luminescence was read for 10 s. Diluted lysates were
also measured to ensure that the values were within the linear
range of the assay. The results presented are the mean of
experiments performed in triplicate.
Western blotting
Western blotting assays were performed as previously
reported (Lan et al., 2004). Western blots were performed
using antibodies specific to EBNA3C, Nm23-H1, and fluores-
cence-labeled secondary antibodies (Rockland, Inc., Gilberts-
ville, PA) followed by detection with an Odyssey Imager
(LiCor, Inc., Lincoln, NE).
Real-time quantitative PCR
Total RNA from 24 h post-transfected cells (vector only,
Nm23-H1, EBNA3C and both Nm23-H1 and EBNA3C) DG75
and BJAB cell lines were isolated using Trizol reagent
(Invitrogen, Inc., Carlsbad, CA) following the manufacturer's
instructions. cDNA was made using a Superscript II RT kit
(Invitrogen, Inc., Carlsbad, CA) according to the manufacturer's
instructions. The specific primers for alpha V integrin used were
as follows: sense, 5′-TGTGCAGCCAATACCCATCTCAAT-
3′; antisense 5′-CGTTCAAACCAGCCAACCAACA-3′ which
yielded a 252-bp PCR product. β-actin was amplified by using
the primers: sense, 5′-GCTCGTCGTCGACAACGGCTC-3′,
antisense, 5′-CAAACATGATCTGGGTCATCTTCTC-3′. This
yielded a 352-bp PCR product. The target gene was amplified
from cDNA using SYBR green real-time master mix (MJ
Research Inc., Waltham, MA), 1 mM each primer and 1 μl of the
cDNA product in a total volume of 20 μl. Thirty-five cycles of
1 min at 94 °C, 1 min at 55 °C and 1 min at 72 °C, followed by
10 min at 72 °C, were performed in an MJ Research Opticon II
thermocycler (MJ Research Inc.,Waltham,MA). Each cycle was
followed by two plate reads, with the first at 72 °C and the
second at 85 °C. A melting curve analysis was performed to
verify the specificity of the products, and the values for the
relative quantitation were calculated by the ΔΔCt method. The
experiment was performed in triplicate.
GST fusion protein preparation, nuclear lysate binding assays
BL21 (E. coli) cells were transformed with pGex2TK-
Nm23-H1 plasmid and selected on ampicillin plate. Over-night grown culture from a single colony was inoculated into
500 ml of LB medium and grown to mid-exponential phase
with shaking. The cells were then induced with 1 mM
isopropyl-B-D-thiogalactopyranoside (IPTG) overnight at
30 °C with shaking. The cells were subsequently harvested,
sonicated and the protein was solubilized. The lysate was
then incubated with Glutathione Sepharose beads overnight
at 4 °C with rotation. The beads were collected by
centrifugation and then washed four times with NETN
(20 mM Tris–HCl (pH 8.0)/100 mM NaCl/1 mM EDTA/
0.5% Nonidet P-40) containing protease inhibitors. The
protein-bound beads were stored at 4 °C in NETN contain-
ing protease inhibitors.
The NIH3T3 Nuclear Extract used in the binding experi-
ments was prepared as described previously (Knight et al.,
2001). The nuclear extract was then precleared with Glutathione
Sepharose beads for 30 min at 4 °C with rotation. The lysates
were additionally precleared with GST-bound Glutathione
Sepharose beads for 1 h at 4 °C with rotation. The lysates
were then incubated with an amount of GST-Nm23-H1 bound
beads, equivalent to the GST bound beads used to preclear and
rotated overnight at 4 °C. SDS lysis buffer with heating was
used to elute the bound protein from the beads followed by 10%
SDS-PAGE. Western blots using anti-GATA-1 antibody were
used to detect the transcription GATA-1 factor associated with
Nm23-H1.
Electrophoresis mobility shift assays (EMSA)
The probes for the GATA-1 and Sp1 binding sites within the
alpha V integrin promoter have been previously described
(Czyz and Cierniewski, 1999; Czyz et al., 2002; Knight et al.,
2001). The probes were end-labeled by Klenow fill-in reaction
with [α-32P] dCTP and purified with NucTrap Probe Purifica-
tion Columns (Stratagene, Inc., La Jolla, CA). Radioactive
probes were diluted in STE (100 mMNaCl, 10 mM Tris pH 7.5,
1 mM EDTA) to a final concentration of 100,000 cpm/μl. DNA
binding reactions and the preparation of nuclear extracts were
performed as described previously (Knight et al., 2001). BJAB
cells were used for preparing nuclear extract. Fifteen micro-
grams of protein from nuclear extracts was mixed with 1 μg
poly (dI–dC) (Sigma) in DNA binding buffer (20 mM HEPES
pH 7.5, 0.01% NP-40, 5.0% glycerol, 10 mMMgCl2, 100 μg of
bovine serum albumin, 1 mM DTT, 1 mM PMSF, 40 mM KCl)
to a total volume of 50 μl and incubated at room temperature for
5 min. One microliter of labeled probe was added to each
reaction followed by an additional 15 min at room temperature.
Cold competitors (200×) were added prior to the initial
incubation at room temperature. Rabbit polyclonal antibodies
against Sp1 and rat monoclonal antibodies of GATA-1 as well
as A10 mouse monoclonal against EBNA3C and anti-myc
ascites were used to supershifting the specific bands. DNA–
protein complexes were resolved on a non-denaturing 6%
PAGE run in 0.5× TBE buffer at a constant voltage of 150 V.
Following electrophoresis, the gels were dried and exposed to a
Phosphor Imager Screen (Amersham Biosciences, Piscataway,
NJ) for 48–72 h.
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protein level
For the determination of the expression of alpha V
integrin protein, 5 million MDA-MB-435 cells from stable
cell line (vector only, Nm23-H1, EBNA3C and both Nm23-
H1 and EBNA3C) were fixed in methanol and then
permeabilized. Cells from each group were incubated with
polyclonal anti-alpha V integrin (2 mg/ml in PBS containing
1% BSA) for 2 h at room temperature and then with FITC-
conjugated isotype-specific secondary antibody for detecting
the respective protein levels for 1 h. Cells were washed
thoroughly and analyzed on a flow cytometer (Becton
Dickinson, San Diego, CA) equipped with 488 nm Argon
laser light source and a 623 nm band pass filter for FITC
fluorescence. A total of 10,000 events were acquired for
analysis using CellQuest software (Becton Dickinson, San
Diego, CA). Cells were properly gated as described earlier,
and histogram plot of FITC fluorescence (x axis) versus
counts (y axis) has been shown in logarithmic fluorescence
intensity.
Immunofluorescence
Immunofluorescence assays were performed essentially as
described previously (Subramanian et al., 2001; Stamenkovic,
2000). Briefly, fixed cells were blocked in the appropriate serum
and then incubated with the specific primary antibody for alpha
V integrins for 1 h. Cells were washed and then further
incubated with the appropriate secondary antibody conjugated
to Alexa Flour 488 at 1:1000 dilutions in phosphate-buffered
saline for 1 h. Slides were washed, visualized with an Olympus
Flouview 300 IX81 inverted confocal microscope, and photo-
graphed with a digital camera and Flouview software
(Olympus, Melville, NY).
In cell Western
We used in cell Western analysis for determination of
autophosphorylation of focal adhesion kinase, a downstream
effector of αvβ3. MDA-MB-435 cells were stably transfected
with EBNA3C, Nm23-H1 and both along with the empty vector
control grown up to 80% confluency in T75 flask. The cells
were collected and diluted to 105 cells/ml in serum free media.
Two hundred microliters of cell suspension was dispensed in
96-well plate (20,000 cells/well) coated with vitronectin
(0.2 μg/cm2). At the same time, the inhibitor of vitronectin
LM609 (25 μg/ml, treated for 24 h) was used as a negative
control. Cells were fixed with 4% formaldehyde for 20 min after
thorough washing with 1× TBS. This is followed by
permeabilization and washing with 0.1% Triton X-100 in 1×
TBS. Cells were then incubated with both FAK (rabbit
polyclonal, 1:1000) and Phospho-FAK (mouse monoclonal
1:1000) antibody overnight. Secondary antibodies Goat anti-
rabbit IRDye 800 and Goat anti-mouse IR Dye 680 (Molecular
Probes, Inc) were used (1:800) and further incubated for 1 h.
Plates were then dried in the dark and scanned for detection inboth the 700 and 800 channels using Odyssey infrared scanning
system.
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